|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 1995;59:867
© 1995 The Society of Thoracic Surgeons
| The first 20% of the full text of this article appears below. |
See also page 863.
DR WILLIAM F. SASSER (St. Louis, MO): It is always a disappointment to learn that a patient has a recurrent or new lung cancer after he or she has been disease free for several years. This paper establishes treatment options and survival statistics that are appropriate for these unfortunate patients. I would like to ask Dr Antakli and associates several questions in their management. Because of the role of increasing managed care, guidance as to the appropriate follow-up studies is necessary. Because many of the new growths were established with computed tomographic scans do you suggest periodic computed tomographic scanning of the chest? If so, at what interval do you repeat the scans?
Second, in the study of your patients is there speculation that a program of adjuvant postoperative chemotherapy would decrease the recurrence or the appearance of a new cancer?
The third comment I would make is that cessation of cigarette smoking must be stressed above all measures.
DR ANTAKLI: Thank you, Dr Sasser. Our policy of following up those patients includes chest roentgenogram and physical examination of the patient every 3 months for three occasions, followed by the same every 6 months for two occasions, and then we
Related Article
Ann. Thorac. Surg. 1995 59: 863-867.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |